SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 48 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,610,000 | -13.2% | 17,960,000 | -10.0% | 0.02% | +10.5% |
| Q1 2022 | $26,058,000 | -40.3% | 19,960,000 | -33.2% | 0.02% | -36.7% |
| Q4 2021 | $43,664,000 | -46.8% | 29,900,000 | -10.9% | 0.03% | -63.0% |
| Q4 2020 | $82,089,000 | -3.3% | 33,560,000 | -16.8% | 0.08% | -18.2% |
| Q3 2020 | $84,921,000 | -10.7% | 40,360,000 | -2.0% | 0.10% | -10.0% |
| Q2 2020 | $95,113,000 | +54.2% | 41,190,000 | +2.4% | 0.11% | +32.5% |
| Q1 2020 | $61,673,000 | -56.7% | 40,240,000 | -43.5% | 0.08% | -36.2% |
| Q4 2019 | $142,581,000 | +137.1% | 71,210,000 | +56.6% | 0.13% | +120.3% |
| Q3 2019 | $60,133,000 | – | 45,460,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
| Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
| CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
| Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
| Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
| Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
| MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |